Akhrass PR, McFarlane SI (2011) Telmisartan and cardioprotection. Vasc Health Risk Manag 7:677–683. https://doi.org/10.2147/vhrm.S9447

Article  PubMed  PubMed Central  CAS  Google Scholar 

Brinkmann V, Ale-Agha N, Haendeler J, Ventura N (2019) The aryl hydrocarbon receptor (AhR) in the aging process: another puzzling role for this highly conserved transcription factor. Front Physiol 10:1561. https://doi.org/10.3389/fphys.2019.01561

Article  PubMed  Google Scholar 

Chang CY, Puga A (1998) Constitutive activation of the aromatic hydrocarbon receptor. Mol Cell Biol 18(1):525–535. https://doi.org/10.1128/mcb.18.1.525

Article  PubMed  PubMed Central  CAS  Google Scholar 

Curran CS, Kopp JB (2022) Aryl hydrocarbon receptor mechanisms affecting chronic kidney disease. Front Pharmacol 13:782199. https://doi.org/10.3389/fphar.2022.782199

Article  PubMed  PubMed Central  CAS  Google Scholar 

Denison MS, Soshilov AA, He G, DeGroot DE, Zhao B (2011) Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor. Toxicol Sci 124(1):1–22. https://doi.org/10.1093/toxsci/kfr218

Article  PubMed  PubMed Central  CAS  Google Scholar 

Deppe S, Böger RH, Weiss J, Benndorf RA (2010) Telmisartan: a review of its pharmacodynamic and pharmacokinetic properties. Expert Opin Drug Metab Toxicol 6(7):863–871. https://doi.org/10.1517/17425255.2010.494597

Article  PubMed  CAS  Google Scholar 

Destro M, Cagnoni F, Dognini GP et al (2011) Telmisartan: just an antihypertensive agent? A Literature Review Expert Opin Pharmacother 12(17):2719–2735. https://doi.org/10.1517/14656566.2011.632367

Article  PubMed  CAS  Google Scholar 

Donovan MG, Selmin OI, Romagnolo DF (2018) Aryl Hydrocarbon Receptor Diet and Breast Cancer Risk. Yale J Biol Med 91(2):105–127

PubMed  PubMed Central  CAS  Google Scholar 

Fang HH, Hsu J, Su JJ (2023) Etoricoxib enhances aryl hydrocarbon receptor activity. Toxicology 499:153658. https://doi.org/10.1016/j.tox.2023.153658

Article  PubMed  CAS  Google Scholar 

Huang S, Shui X, He Y et al (2015) AhR expression and polymorphisms are associated with risk of coronary arterial disease in Chinese population. Sci Rep 5:8022. https://doi.org/10.1038/srep08022

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kim SH, Henry EC, Kim DK et al (2006) Novel compound 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazo-phenyl)-amide (CH-223191) prevents 2,3,7,8-TCDD-induced toxicity by antagonizing the aryl hydrocarbon receptor. Mol Pharmacol 69(6):1871–1878. https://doi.org/10.1124/mol.105.021832

Article  PubMed  CAS  Google Scholar 

Kou Z, Dai W (2021) Aryl hydrocarbon receptor: Its roles in physiology. Biochem Pharmacol 185:114428. https://doi.org/10.1016/j.bcp.2021.114428

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kumar A, Sodhi M, Mukesh M et al (2023) Identification of stably expressed Internal Control Genes (ICGs) for normalization of expression data in liver of C57BL/6 mice injected with beta casomorphins. PLoS ONE 18(5):e0282994. https://doi.org/10.1371/journal.pone.0282994

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kusunoki H, Taniyama Y, Azuma J et al (2012) Telmisartan exerts renoprotective actions via peroxisome proliferator-activated receptor-γ/hepatocyte growth factor pathway independent of angiotensin II type 1 receptor blockade. Hypertension 59(2):308–316. https://doi.org/10.1161/hypertensionaha.111.176263

Article  PubMed  CAS  Google Scholar 

Larigot L, Juricek L, Dairou J, Coumoul X (2018) AhR signaling pathways and regulatory functions. Biochim Open 7:1–9. https://doi.org/10.1016/j.biopen.2018.05.001

Article  PubMed  PubMed Central  Google Scholar 

Mann JF, Schmieder RE, McQueen M et al (2008) Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet 372(9638):547–553. https://doi.org/10.1016/s0140-6736(08)61236-2

Article  PubMed  CAS  Google Scholar 

Nakano A, Hattori Y, Aoki C, Jojima T, Kasai K (2009) Telmisartan inhibits cytokine-induced nuclear factor-kappaB activation independently of the peroxisome proliferator-activated receptor-gamma. Hypertens Res 32(9):765–769. https://doi.org/10.1038/hr.2009.95

Article  PubMed  CAS  Google Scholar 

Opitz CA, Litzenburger UM, Sahm F et al (2011) An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 478(7368):197–203. https://doi.org/10.1038/nature10491

Article  PubMed  CAS  Google Scholar 

Poland A, Glover E, Kende AS (1976) Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase. J Biol Chem 251(16):4936–46

Roth GA, Abate D, Abate KH et al (2018) Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392(10159):1736–1788. https://doi.org/10.1016/s0140-6736(18)32203-7

Article  Google Scholar 

Seong E, Lee JH, Lim S et al (2021) Activation of aryl hydrocarbon receptor by ITE improves cardiac function in mice after myocardial infarction. J Am Heart Assoc 10(13):e020502. https://doi.org/10.1161/jaha.120.020502

Article  PubMed  PubMed Central  CAS  Google Scholar 

Song J, Clagett-Dame M, Peterson RE et al (2002) A ligand for the aryl hydrocarbon receptor isolated from lung. Proc Natl Acad Sci USA 99(23):14694–14699. https://doi.org/10.1073/pnas.232562899

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wang Q, Chen J, Ko CI et al (2013) Disruption of aryl hydrocarbon receptor homeostatic levels during embryonic stem cell differentiation alters expression of homeobox transcription factors that control cardiomyogenesis. Environ Health Perspect 121(11–12):1334–1343. https://doi.org/10.1289/ehp.1307297

Article  PubMed  PubMed Central  Google Scholar 

Wei KL, Chen FY, Lin CY et al (2016) Activation of aryl hydrocarbon receptor reduces carbendazim-induced cell death. Toxicol Appl Pharmacol 306:86–97. https://doi.org/10.1016/j.taap.2016.06.004

Article  PubMed  CAS  Google Scholar 

Wei KL, Gao GL, Chou YT et al (2022) Sorafenib is an antagonist of the aryl hydrocarbon receptor. Toxicology 470:153118. https://doi.org/10.1016/j.tox.2022.153118

Article  PubMed  CAS  Google Scholar 

Yusuf S, Teo K, Anderson C et al (2008) Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. Lancet 372(9644):1174–1183. https://doi.org/10.1016/s0140-6736(08)61242-8

Article  PubMed  CAS  Google Scholar